These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17468024)

  • 1. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs.
    Volk HA; Matiasek LA; Luján Feliu-Pascual A; Platt SR; Chandler KE
    Vet J; 2008 Jun; 176(3):310-9. PubMed ID: 17468024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment into the usage of levetiracetam in a canine epilepsy clinic.
    Packer RM; Nye G; Porter SE; Volk HA
    BMC Vet Res; 2015 Feb; 11():25. PubMed ID: 25889090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-blinded phenobarbital-controlled trial of levetiracetam as mono-therapy in dogs with newly diagnosed epilepsy.
    Fredsø N; Sabers A; Toft N; Møller A; Berendt M
    Vet J; 2016 Feb; 208():44-9. PubMed ID: 26639829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Papich MG
    J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imepitoin withdrawal in dogs with idiopathic epilepsy well-controlled with imepitoin and phenobarbital and/or potassium bromide does not increase seizure frequency.
    Stee K; Martlé V; Broeckx BJG; Royaux E; Van Ham L; Bhatti SFM
    Vet J; 2017 Dec; 230():1-5. PubMed ID: 29208209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam monotherapy for treatment of structural epilepsy in dogs: 19 cases (2010-2015).
    Kelly D; Raimondi F; Shihab N
    Vet Rec; 2017 Oct; 181(15):401. PubMed ID: 28847876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromide therapy in refractory canine idiopathic epilepsy.
    Podell M; Fenner WR
    J Vet Intern Med; 1993; 7(5):318-27. PubMed ID: 8263851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing serum concentrations of levetiracetam in dogs with epilepsy.
    Saint-Maxent M; Juette T; Parent J; Castel A; Parmentier T
    J Vet Intern Med; 2024; 38(4):2249-2256. PubMed ID: 38888491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of levetiracetam as adjunctive treatment for refractory canine epilepsy: a randomized, placebo-controlled, crossover trial.
    Muñana KR; Thomas WB; Inzana KD; Nettifee-Osborne JA; McLucas KJ; Olby NJ; Mariani CJ; Early PJ
    J Vet Intern Med; 2012; 26(2):341-8. PubMed ID: 22295869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenobarbital or potassium bromide as an add-on antiepileptic drug for the management of canine idiopathic epilepsy refractory to imepitoin.
    Royaux E; Van Ham L; Broeckx BJ; Van Soens I; Gielen I; Deforce D; Bhatti SF
    Vet J; 2017 Feb; 220():51-54. PubMed ID: 28190495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiopathic epilepsy in dogs: owners' perspectives on management with phenobarbitone and/or potassium bromide.
    Chang Y; Mellor DJ; Anderson TJ
    J Small Anim Pract; 2006 Oct; 47(10):574-81. PubMed ID: 17004949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam as an adjunct to phenobarbital treatment in cats with suspected idiopathic epilepsy.
    Bailey KS; Dewey CW; Boothe DM; Barone G; Kortz GD
    J Am Vet Med Assoc; 2008 Mar; 232(6):867-72. PubMed ID: 18341442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving seizure control in dogs with refractory epilepsy using gabapentin as an adjunctive agent.
    Govendir M; Perkins M; Malik R
    Aust Vet J; 2005 Oct; 83(10):602-8. PubMed ID: 16255282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin as an adjunct to phenobarbital, potassium bromide, or a combination of phenobarbital and potassium bromide for treatment of dogs with suspected idiopathic epilepsy.
    Dewey CW; Cerda-Gonzalez S; Levine JM; Badgley BL; Ducoté JM; Silver GM; Cooper JJ; Packer RA; Lavely JA
    J Am Vet Med Assoc; 2009 Dec; 235(12):1442-9. PubMed ID: 20001779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.
    Neßler J; Rundfeldt C; Löscher W; Kostic D; Keefe T; Tipold A
    BMC Vet Res; 2017 Jan; 13(1):33. PubMed ID: 28118828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy.
    Ben-Menachem E; Gilland E
    Seizure; 2003 Apr; 12(3):131-5. PubMed ID: 12651076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy.
    Abou-Khalil B; Hemdal P; Privitera MD
    Seizure; 2003 Apr; 12(3):141-9. PubMed ID: 12651078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic epilepsy in dogs and cats.
    Thomas WB
    Vet Clin North Am Small Anim Pract; 2010 Jan; 40(1):161-79. PubMed ID: 19942062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.